Mucosal passive immunization with monoclonal antibodies targeting Candidalysin and Hyr proteins attenuates vaginal candidiasis in mice

Vulvovaginal candidiasis (VVC) is a prevalent fungal infection primarily caused by the opportunistic pathogen Candida albicans. Among women affected by VVC, up to 8% experience more than four episodes per year, regarded as recurrent vulvovaginal candidiasis (RVVC). Current treatments for VVC are eff...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Julie Auffray, Nicolas Biteau, Anne Cayrel, Denis Dacheux, Hassana Hsein, Pierre Tchoreloff, Thierry Noel
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Taylor & Francis Group 2025-12-01
Serie:	Virulence
Soggetti:	Candida albicans vulvovaginal candidiasis passive mucosal immunization Candidalysin Hyr1 monoclonal antibody
Accesso online:	https://www.tandfonline.com/doi/10.1080/21505594.2025.2569629
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!